Photo via Toronto Star

Senators to question FDA nominee about her views on abortion pill and vaccines

Read the original at Toronto Star ↗
Cite

Perrone, M. (2026, September 24). Senators to question FDA nominee about her views on abortion pill and vaccines. Toronto Star. https://www.thestar.com/news/world/senators-to-question-fda-nominee-about-her-views-on-abortion-pill-and-vaccines/article_4ca2736b-ab19-54ef-bf8a-d153f210fc06.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-09-24 · by Matthew Perrone

Quick Summary

Dr. Heidi Overton, President Trump's nominee for the FDA position, faces Senate questioning on Thursday regarding her stance on vaccines, abortion pills like mifepristone, and other controversial health policies. As a White House aide and executive at conservative groups, Overton has authored papers critical of abortion and transgender care, positions that may challenge her confirmation process. Senator Bill Cassidy, among others, views her support for spacing out vaccinations as concerning, while also seeing potential alignment on restricting access to mifepristone.
Written by AI on 2026-09-24, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Dr. Heidi Overton, President Donald Trump’s nominee to head the Food and Drug Administration (FDA), faced intense questioning from Senate lawmakers on September 24 regarding her stance on vaccines, abortion pills like mifepristone, and other contentious health issues. Senators, particularly Republicans like Sen. Bill Cassidy of Louisiana, focused heavily on Overton’s views on restricting access to the abortion pill mifepristone, which has been approved by the FDA since 2000 despite recent efforts to tighten regulations under conservative pressure.

During her confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, Overton often dodged direct questions about specific policies, citing technical aspects of her potential role as commissioner. This approach upset both Democrats and Republicans who wanted more definitive answers on issues such as vaccine safety and abortion access. For instance, Sen. Chris Murphy criticized Overton for avoiding straightforward responses.

The hearing was marked by concerns over the FDA's oversight under Trump’s administration, including an executive order signed in August 2025 calling for splitting up the combined MMR vaccine into three separate shots—a move based on misinformation about vaccine safety. Despite these controversies, Overton maintained that “the MMR vaccine is currently licensed and approved by the FDA,” highlighting its importance during a significant measles outbreak with four deaths reported in Pennsylvania in 2026 due to low vaccination rates.

Written for “FDA Nominee Confirmation Hearing” on 2026-10-31, grounded in this article and the 3 other(s) covering the same event.

Story

📰 FDA Nominee Confirmation Hearing
Politics · 4 article(s) covering the same event. Compare every outlet's account →

Compared with similar articles

This article reads leans right and hedges 16% of its claims. Each row says how that neighbour differs.
NBC News
⚖️ Leans strongly right further right than this Hedges 3 of 26 claims Outlet record 60/100
The Straits Times
Hedges 2 of 13 claims Outlet record 66/100
Washington Examiner
Hedges 1 of 20 claims Outlet record 70/100
Fox News
⚖️ Leans right Hedges 2 of 30 claims Outlet record 69/100
“While both articles mention Dr. Heidi Overton and her confirmation hearing for FDA nomination on the same day, they describe different events: one about senators questioning her views, and the other about a pro-life group threatening to sue the FDA over environmental risks of an abortion drug.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
31
sentences that state something as happening or true
Uncertain
16%
5 of 31 hedged ("reportedly", "may", "according to")
Leaning
Leans right
of the writing, not the subject · beta estimate
Publisher signals
64/100
Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
4
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Toronto Star · 10784 article(s) · 28 correction(s) detected
Running correction rate · 28 correction(s)
2026-10-26
Correction
2026-10-24
Correction
2026-10-07
Correction
2026-09-24
Correction

Who wrote this

Matthew Perrone
8 article(s) here · 1 carrying a prediction
🔮 The effort on peptides, driven by Kennedy’s Department of Health and Human Services, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency’s longstanding mission of keeping unproven health products off the U.S. market, according to the people familiar with its development.
🔮 The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use curtailed.
🔮 At a MAHA summit featuring AI and Silicon Valley executives, Kennedy declared that the technology would free Americans from “medical tyranny” by allowing them to “fact check their own medical advice.”
🔮 WASHINGTON (AP) — President Donald Trump’s nominee to take over the Food and Drug Administration is set to answer questions Thursday, with Senate lawmakers likely to focus on her plans for vaccines, the abortion pill and other products that have come under new scrutiny at the regulatory agency.
🔮 Your data may be shared with advertisers, social media companies and others Americans often assume that any personal health information they share is protected by HIPAA, the federal privacy law that governs the handling of medical information.
🔮 The new clinical guidance, released late Thursday, outlines how the program would work.
🔮 The new clinical guidance, released late Thursday, outlines how this program will function.
Also by Matthew Perrone
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 8 articles by Matthew Perrone →

Topics

FDA Health Senate White House the America First Policy Institute

Subjects

Overton PERSON · 9× FDA ORG · 7× Senate ORG · 5× Trump PERSON · 5× White House ORG · 3× Cassidy PERSON · 2× Health ORG · 2× Republicans NORP · 2× WASHINGTON GPE · 2× the America First Policy Institute ORG · 2×

Narrative

Cassidy and several colleagues have spent months urging the FDA to restrict access to mifepristone, the pill currently used in most abortions in the U.S. The FDA first approved mifepristone in 2000 and has repeatedly affirmed its safety while broadening access, including allowing it to be sent through the mail.
framing: assertive · carried by 1 article(s) · first seen 2026-09-24
🔮 WASHINGTON (AP) — President Donald Trump’s nominee to take over the Food and Drug Administration is set to answer questions Thursday, with Senate lawmakers likely to focus on her plans for vaccines, the abortion pill and other products that have come under new scrutiny at the regulatory agency.

Claims (31 extracted, 5 hedged)

WASHINGTON (AP) — President Donald Trump’s nominee to take over the Food and Drug Administration is set to answer questions Thursday, with Senate lawmakers likely to focus on her plans for vaccines, the abortion pill and other products that have come under new scrutiny at the regulatory agency. asserted
that → take → agency
Dr. Heidi Overton, a physician and top White House aide, has spent most of her career working for Trump or conservative groups aligned with his agenda. asserted
Overton → spend → agenda
That connection may prompt questions from some members of the Senate health committee which is considering her nomination. uncertain
which → prompt → nomination
In her current role as a domestic policy adviser, Overton worked on several White House health initiatives, including the revamped food pyramid and efforts to overhaul childhood vaccines. asserted
Overton → work → vaccines
Previously she was an executive at the America First Policy Institute, authoring papers critical of abortion and transgender care. asserted
she → author → abortion
During Trump’s first term, she served as a White House fellow. asserted
she → serve → fellow
If confirmed by the Senate, Overton would inherit a raft of controversial projects, including a safety review of the nation’s principal abortion drug, a plan to break up combination vaccines and new rules that make it easier to sell flavored electronic cigarettes. asserted
it → confirm → cigarettes
All three policies break from FDA’s longstanding positions, especially on the safety of childhood vaccines. asserted
policies → break → vaccines
Overton stood beside Trump and Health Secretary Robert F. Kennedy in the Oval Office last month when they falsely suggested that the use of combination vaccines could be a contributor to autism. uncertain
use → stand → autism
Health committee chairman Sen. Bill Cassidy, a physician from Louisiana, called Overton’s support for that plan to space out vaccinations “almost disqualifying.” But Cassidy and other Senate Republicans may find common ground with Overton on abortion. uncertain
Cassidy → call → abortion
Cassidy and several colleagues have spent months urging the FDA to restrict access to mifepristone, the pill currently used in most abortions in the U.S. The FDA first approved mifepristone in 2000 and has repeatedly affirmed its safety while broadening access, including allowing it to be sent through the mail. asserted
it → spend → mail
But Kennedy ordered a reevaluation of the drug’s safety last year, following calls from anti-abortion groups and lawmakers aligned with Trump. asserted
Kennedy → order → Trump
FDA officials have said almost nothing about the review, except that it is ongoing. asserted
it → say → review
While working at the America First Policy Institute, Overton blasted the FDA’s 2023 decision — under President Joe Biden — to allow mail delivery of mifepristone, referring to the practice as “chemical abortion on demand.” asserted
Overton → work → demand
She was similarly critical of the administration’s approach to transgender care for children, including providing access to puberty-blocking drugs and gender-affirming surgeries. asserted
She → include → drugs
Overton co-authored a 2024 article about then-vice presidential candidate and Minnesota governor Tim Walz, titled: “Tim Walz Made Minnesota A ‘Sanctuary’ For Baby Killers And Child Mutilators.” asserted
Minnesota → co → Killers
Overton’s abortion views could complicate her efforts to win over two moderate Republicans on the panel: Maine Sen. Susan Collins and Alaska Sen. Lisa Murkowski. uncertain
views → complicate → panel
Both have bucked their party on the issue, supporting federal access to abortion. asserted
Both → buck → abortion
Collins is currently locked in a tight reelection race where abortion access is a central issue. asserted
access → lock → race
To become commissioner, Overton will need a majority of votes from the 21-member health committee, followed by a positive vote from the full Senate. asserted
Overton → become → Senate
Headquartered in the suburbs outside Washington, the FDA oversees U.S. medical products plus billions of dollars in food, cosmetics, tobacco and vaping products. asserted
FDA → oversee → food
Under the current administration, leading the agency has involved balancing Trump’s demands for slashing regulations — such as those for vaping products — alongside Kennedy’s interests in scrutinizing vaccines, drugs and food ingredients. asserted
leading → lead → vaccines
Those challenges dogged the tenure of the previous FDA head, Dr. Marty Makary, who resigned in May. uncertain
who → dog → May
Makary’s time at the agency was defined by scientific disputes, leadership changes and a string of media stories detailing low morale and internal dysfunction among staffers. asserted
time → define → staffers
The FDA has lost about 20% of its employees to layoffs, buyouts, retirements or resignations since Trump took office. asserted
Trump → lose → office
Overton studied under Makary at Johns Hopkins University, where she received a doctoral degree in clinical research after earning her medical degree at the University of New Mexico. asserted
she → study → Mexico
Like Makary, Overton has no experience running a large bureaucracy, a critical skill for steering the FDA’s 16,000 staffers spread across numerous U.S. and international locations. asserted
Overton → have → locations
In financial disclosure forms, Overton reported no investments in health care or food companies. asserted
Overton → report → companies
That’s a stark contrast to Makary and other recent FDA nominees who have had to divest investments or cut other financial ties with companies regulated by the FDA. asserted
who → ’ → FDA
Overton reported $50,000 to $100,000 in student loans. asserted
Overton → report → loans
The Associated Press’ health and science coverage receives financial support from the AP Fund for Journalism and private foundations. asserted
coverage → receive → Journalism
💬Give feedback
🕘History 🎫Support